Gender differences in the pharmacology of nicotine addiction

Addiction Biology

Volumn 3, Issue 4, 1998, Pages 383-404

  Benowitz, Neal L ^a,c   Hatsukami, Dorothy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CLONIDINE; DOPAMINE RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; PSYCHOTROPIC AGENT; SEX HORMONE;

AFFECTIVE NEUROSIS; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; MENSTRUAL IRREGULARITY; MOOD; NONHUMAN; PHARMACODYNAMICS; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SUBSTITUTION THERAPY; WEIGHT REDUCTION;

EID: 0031689665     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556219871930     Document Type: Review

References (191)

1. Fiore MC, Novotny TE, Pierce JP, Hatziandreu EJ, Patel KM, Davis RM. Trends in cigarette smoking in the United States. The changing influence of gender and race. J Am Med Assoc 1989;261:49-55.
2. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev 1995;17:48-65.
3. Kandel D, Chen K, Warner LA, Kessler RC, Grant B. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend 1997;44:11-29.
4. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol 1994;2:244-68.
5. Breslau N, Kilbey MM, Andreski P. DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction 1994;89:743-54.
6. Stapleton JA, Russell MAH, Feyerabend C et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995;90:31-42.
7. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. Br Med J 1994;309:842-6.
8. Bjornson W, Rand C, Connett JE, et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995; 85:223-30.
9. Sachs DPL, Säwe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993;153:1881-90.
10. Swan GE, Ward MM, Carmelli D, Jack LM. Differential rates of relapse in subgroups of male and female smokers. J Clin Epidemiol 1993;46: 1041-53.
11. Department of Health and Human Services PHS. The health consequences of smoking: nicotine addiction. A report of the Surgeon General. DHHS (CDC) Publication No. 88-8406. Washington DC: Government Printing Office; 1988.
12. Benowitz NL. Cigarette smoking and nicotine addition. Med Clin N Am 1992;76:415-37.
13. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Ann Rev Pharmacol Toxicol 1996;36:597-613.
14. Henningfield JE, Schuh LM, Jarvik ME. Pathophysiology of tobacco dependence. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press;1995, pp. 1715-29.
15. LeHouezec, J, Benowitz NL. Basic and clinical psychopharmacology of nicotine. Clin Chest Med 1991;12:681-99.
16. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993;33:23-9.
17. Benowitz NL. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. In: Chiang CN, Hawks RL, editors. Research findings on smoking of abused substances, NIDA Research Monograph 99. Washington DC: Supt of Documents; 1990, pp. 12-29.
18. Armitage AK, Dollery CT, George CF, Houseman TH, Lewis PJ, Turner DM. Absorption and metabolism of nicotine from cigarettes. Br Med J 1975;4:313-16.
19. Iwase A, Aiba M, Kira S. Respiratory nicotine absorption in nonsmoking females during passive smoking. Int Arch Occup Environment Health 1991;63:139-43.
20. Benowitz NL, Porchet H, Jacog P III. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP, editors. Nicotine psychopharmacology: molecular, cellular and behavioral aspects. Oxford: Oxford University Press; 1990, pp. 112-57.
21. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27-39.
22. Rosecrans JA. Brain area nicotine levels in male and female rats with different levels of spontaneous activity. Neuropharmacology 1972;11: 863-70.
23. Rosecrans JA, Schechter MD. Brain area nicotine levels in male and female rats of two strains. Arch Int Pharmacodynamie 1972;196:46-54.
24. Hatchell PC, Collins AC. The influence of geno-type and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology 1980;71:45-9.
25. Benowitz NL, Jacob P III, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
26. Benowitz NL, Jacob P III. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther 1985;234:153-5.
27. Benowitz NL, Jacob P III. Metabolism of nicotine to continine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-93.
28. Byrd GD, Chang K, Greene JM, deBethizy JD. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxy-cotinine in smokers. Drug Metab Disp 1992;20: 192-7.
29. Beckett AH, Gorrod JW, Jenner P. The effect of smoking on nicotine metabolism in vivo in man. J Pharm Pharmacol 1971;23:62S-67S.
30. Kyerematen GA, Owens GF, Chattopadhyay B, deBethizy JD, Vesell ES. Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro. Drug Metab Disp 1988;16:823-8.
31. Seaton M, Kyerematen GA, Morgan M, Jeszenka EV, Vesell ES. Nicotine metabolism in stump-tailed macaques, Macaca arctoides. Drug Metab Disp 1991;19:946-54.
32. Stalhandski T, Slanina P, Tjalve H, Hansson G, Schmiterlow CG. Metabolism in view of 14C-nicotine in livers of foetal, newborn and young mice. Acta Pharmacol Toxicol 1969;27:363-80.
33. Jenner P, Gorrod JW. Comparative in vitro hepatic metabolism of some tertiary N-methyl tobacco alkaloids in various species. Res commun Clin Pathol Pharmacol 1973;6:829-43.
34. Jenner P, Gorrod JW, Beckett AH. Species variation in the metabolism of (R)-(+)- and S-(-)-nicotine by a-C- and N-oxidation in vitro. Xenobiotica 1973;3:573-80.
35. Benowitz NL, Jacob P III. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
36. Moody PM. The relationships of quantified human smoking behavior and demographic variables. Soc Sci Med 1980;14A:49-54.
37. Battig K, Buzzi R, Nil R. Smoke yield of cigarettes and puffing behavior in men and women. Psychopharmacology 1982;76:139-48.
38. Epstein LH, Dickson BE, Ossip DJ, Stiller R, Russell PO, Winter K. Relationships among measures of smoking topography. Addict Behav 1982;7:307-10.
39. Hofer I, Nil R, Battig K. Nicotine yield as determinant of smoke exposure indicators and puffing behavior. Pharmacol Biochem Behav 1991;40: 139-49.
40. Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacol Biochem Behav 1991;53:355-60.
41. Perkins KA, Epstein LH, Fonte C, Mitchell SL, Grobe JE. Gender, dietary restraint, and smoking's influence on hunger and the reinforcing value of food. Physiol Beahv 1995;57:675-80.
42. Russell MAH, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J 1980;280:972-6.
43. Russell MAH, Jarvis MJ, Feyerabend C, Saloojee Y. Reduction of tar, nicotine and carbon monoxide intake in low tar smokers. J Epidemiol Commun Health 1986;40:80-5.
44. Woodward M, Tunstall-Pedoe H. Self-titration of nicotine: evidence from the Scottish Heart Health Study. Addiction 1993;88:821-30.
45. Wagenknecht LE, Cutter GR, Haley NJ et al. Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study. Am J Public Health 1990;80:1053-6.
46. Gori GB, Lynch CJ. Analytical cigarette yields as predictors of smoke bioavailability. Regul Toxicol Pharmacol 1985;5:314-26.
47. Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman AL. Smokers of low yield cigarettes do not consume less nicotine. N Engl J Med 1983;309:139-42.
48. Changeux JP, Galzi JL, Devillers-Thiery A, Betrand D. The functional architecture of the acetylcholine nicotinic receptor explored by affinity labeling and site-directed mutagenesis. Q Rev Biophys 1992;25:395-432.
49. 125I]abungarotoxin. J Neurosci 1985;5:1307-15.
50. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Ann Rev Physiol 1995;57: 521-46.
51. Lena C, Changeux J-P. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci 1993;16:181-6.
52. Collins AC, Luo Y, Selvaag S, Marks MJ. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 1994;271: 125-33.
53. 3H]nicotine binding sites in human brain. J Neurochem 1988;50:1243-7.
54. 3H]nicotine binding in human post-mortem brain. J Pharmacol Exp Ther 1997;282: 7-13.
55. McGehee DS, Heath MJS, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 1995;269:1692-6.
56. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994;653:278-84.
57. Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Nat Acad Sci USA 1992;89: 9949-53.
58. 2 dopamine receptor binding. Brain Res 1994;637: 163-72.
59. 1 dopamine receptors in the rat striatum. Brain Res 1988;442:349-50.
60. Levesque D, DiPaolo T. Effect of the rat estrous cycle at ovariectomy on striatal D1I dopamine receptor. Brain Res Bull 1990;24:281-4.
61. Castner SA, Xiao L, Becker JB. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res 1993;610:127-34.
62. Gordon JH. Modulation of apomorphine-induced sterotypy by estrogen: time course and dose response. Brain Res Bull 1980;5:679-82.
63. Andersson K, Eneroth P, Fuxe K, Harfstrand A. Effects of acute intermittent exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on neuroendocrine function in the diestrous rat. Naunyn-Schmiedeberg's Arch Pharmacol 1988;337: 131-9.
64. Jansson A, Andresson K, Fuxe K, Bjelke B, Eneroth P. Effects of combined pre- and postnatal treatment with nicotine on hypothalamic catecholamine nerve terminal systems and neuroendocrine function in the four week old and adult male and female diestrous rat. J Neuroendocrinol 1989;1: 455-64.
65. Grunberg NE, Winders SE, Popp KA. Sex differences in nicotine's effects on consummatory behavior and body weight in rats. Psychopharmacology 1987;91:221-5.
66. Perkins KA, Epstein LH, Grobe JE, Fonte C. Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacol Biochem Behav 1994;47:107-12.
67. Perkins KA, Grobe JE, D'Amico D, Fonte C, Scierka A, Stiller RL. Low-dose nicotine nasal spray use and effects during initial smoking cessation. Exp Clin Psychopharmacol 1996;4:157-65.
68. Perkins KA. Sex differences in nicotine versus non-nicotine reinforcement as determinants of tobacco smoking. Exp Clin Psychopharmacol 1996;4:166-77.
69. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler J. Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 1992;52:627-34.
70. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL. Nicotine discrimination in male and female smokers. Psychopharmacology 1994;116: 407-13.
71. Perkins KA, Grobe JE, D'Amico D, Sanders M, Scierka A, Stiller RL. Effect of training dose on nicotine discrimination in smokers. In: Harris LS, editor. Problems of drug dependence 1995: proceedings of the 57th annual scientific meeting. Washington DC: National Institute on Drug Abuse Research Monograph No. 162; 1996, p. 288.
72. Perkins KA. Individual variability in responses to nicotine. Behav Genet 1995;25:119-32.
73. Pomerleau CS, Pomerleau OF. Euphoriant effects of nicotine in smokers. Psychopharmacology 1992;108:460-5.
74. Henningfield JE, London ED, Jaffe JH. Nicotine reward: studies of abuse liability and physical dependence potential. In: Engel J, Oreland L, editors. Brain reward systems and abuse. New York: Raven Press; 1987, pp. 147-64.
75. Henningfield JE, Miyasato K, Jasinski DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 1985;234:1-12.
76. Pomerleau OF, Rosecrans J. Neuroregulatory effects of nicotine. Psychoneuroendocrinology 1989;14:407-23.
77. Parrott AC. Individual differences in stress and arousal during cigarette smoking. Psychopharmacology 1994;115:389-96.
78. Perkins KA, Grobe JE, Epstein LH, Caggiula A, Stiller RL, Jacob RG. Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav 1993;45:375-81.
79. Pomerleau CS, Cole PA, Lumley MA, Marks JL, Pomerlcau OF. Effects of menstrual phase on nicotine, alcohol and caffeine intake in smokers. J Substance Abuse 1994;6:227-34.
80. Perkins KA, Grobe JE, Fonte C et al. Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 1994;270:628-38.
81. Perkins KA, Sexton JE, Reynolds WA, Grobe JE, Fonte C, Stiller RL. Comparison of acute subjective heart rate effects of nicotine intake via tobacco smoking versus nasal spray. Pharmacol Biochem Behav 1994;47:295-9.
82. Perkins KA, Grobe JE. Increased desire to smoke during acute stress. Br J Addict 1992;87:1037-40.
83. Schachter S. Pharmacological and psychological determinants of smoking. Ann Intern Med 1978; 88:104-14.
84. Dobbs SD, Strickler DP, Maxwell WE. The effects of stress and relaxation in the presence of stress on urinary pH and smoking behavior. Addict Behav 1981;6:345-53.
85. Pomerleau CS, Pomerleau OF. The effects of a psychological stressor on cigarette smoking and subsequent behavioral and physiological responses. Psychophysiology 1987;24:278-85.
86. Pomerleau OF, Pomerleau CS. Stress, smoking and the cardiovascular system. J Substance Abuse 1989;1:331-43.
87. Rose JE, Ananda S, Jarvik ME. Cigarette smoking during anxiety provoking and monotonous tasks. Addict Behav 1983;8:353-9.
88. Frith CD. Smoking behavior and its relation to the smoker's immediate experience. Br J Soc Clin Psychol 1971;10:73-8.
89. Ikard FF, Tomkins S. The experience of affect as a determinant of smoking behavior: a series of validity studies. J Abnormal Psychol 1973;81: 172-81.
90. Sorensen G, Pechacek TF. Attitudes toward smoking cessation among men and women. J Behav Med 1987;10:129-37.
91. Livson N, Leino EV. Cigarette smoking motives: factorial structure and gender differences in a longitudinal study. Int J Addict 1988;23:535-44.
92. Russell MAH, Peto J, Patel UA. The classification of smoking by factorial structure of motives. J Roy Statist Soc Assoc 1974;137:313-33.
93. Oakley A, Brannen J, Dodd K. Young people, gender and smoking in the United Kingdom. Health Prom Int 1992;7:75-88.
94. Pomerleau CS, Pomerleau OF, Garcia AW. Biobehavioral research on nicotine use in women. Br J Addict 1991;86:527-31.
95. Solomon LJ, Flynn BS. Women who smoke. In: Orleans CT, Slade J, editors. Nicotine addiction principles and management. New York: Oxford University Press; 1993, pp. 339-88.
96. O'Neill ST, Parrott AC. Stress and arousal in sedative and stimulant cigarette smokers. Psychopharmacology 1992;107:442-6.
97. Pomerleau OF, Turk DC, Fertig JB. The effects of cigarette smoking on pain and anxiety. Addict Behav 1984;9:265-71.
98. Perkins KA, Grobe JE, Fonte C, Breus M. "Paradoxical" effects of smoking on subjective stress versus cardiovascular arousal in males and females. Pharmacol Biochem Behav 1992;42: 301-11.
99. Parrott AC, Joyce C. Stress and arousal rhythms in cigarette smokers, deprived smokers, and nonsmokers. Hum Psychopharmacol 1993;8:21 8.
100. Epstein LH, Dickson BE, McKenzie S, Russell PO. The effect of smoking on perception of muscle tension. Psychopharmacology 1984;83: 107-13.
101. Heishman SJ, Taylor RC, Henningfield JE. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 1994;2: 345-95.
102. Grunberg NE. The inverse relationship between tobacco use and body weight. In: Kozlowski LT, Annis HM, Chappel HD, et al., editors. Research advances in alcohol and drug problems. New York: Plenum Press; 1990, pp. 273-315.
103. Camp DE, Klesges RC, Relyea G. The relationship between body weight concerns and adolescent smoking. Health Psychol 1993;12:24-32.
104. Gritz ER, Klesges RC, Meyers AW. The smoking and body weight relationship: implications for intervention and postcessation weight control. Ann Behav Med 1989;11:144-53.
105. Wetter DW, Smith SS, Kenford SL et al. Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. J Abnormal Psychol 1994;103:801-11.
106. Klesges RC, Meyers AW, Klesges LM, La Vasque ME. Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull 1989;2:204-30.
107. Klesges RC, Klesges LM, Meyers AW. Relationship of smoking status, energy balance, and body weight: analysis of the Second National Health and Nutrition Examination Survey. J Consult Clin Psychol 1991;59:899-905.
108. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991;324:739-45.
109. Leischow SJ, Sachs DPL, Bostrom AG, Hansen MD. Effects of differing nicotine-replacement on weight gain after smoking cessation. Arch Fam Med 1992;1:233-7.
110. Doherty K, Militello FS, Kinnunen T, Garvey AJ. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 1996;64: 799-807.
111. Grunberg NE, Bowen DJ, Winders SE. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology 1986;90:101-5.
112. Perkins KA. Effects of tobacco smoking on caloric intake. Br J Addict 1992;87:193-205.
113. Ogden J, Fox P. Examination of the use of smoking for weight control in restrained and unrestrained eaters. Int J Eating Dis 1994;16:177-85.
114. French SA, Perry CL, Leon GR, Fulkerson JA. Weight concerns, dieting behavior, and smoking initiation among adolescents: a prospective study. Am J Public Health 1994;84:1818-20.
115. Perkins KA. Metabolic effects of cigarette smoking. J Appl Physiol 1992;72:401-9.
116. Perkins KA, Epstein LH, Sexton JE, Stiller RL, Jacog RG. Effects of dose, gender, level of physical activity on acute metabolic response to nicotine. Pharmacol Biochem Behav 1991;40:203-8.
117. Perkins KA, Sexton JE, Epstein LH et al. Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers. Am J Clin Nutr 1994;60:312-19.
118. Palmer AB. Some variables contributing to the onset of cigarette smoking among junior high school students. Soc Sci Med 1970;4:359-66.
119. Silverstein B, Feld S, Kozlowski LT. The availability of low-nicotine cigarettes as a cause of cigarette smoking among teenage females. J Health Soc Behav 1980;21:383-8.
120. Balfour DJ. Neural mechanisms underlying nicotine dependence. Addiction 1994;89:1419-23.
121. Porchet HC, Benowitz NL, Sheiner LB. Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 1988;244:231-6.
122. Fattinger K, Verotta D, Benowitz NL. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther 1997; 281:1238-46.
123. Arcavi L, Jacob P III, Hellerstein M, Benowitz NL. Divergent tolerance to metabolic and cardiovascular effects of nicotine in smokers with low and high levels of cigarette consumption. Clin Pharmacol Ther 1994;56:55-64.
124. Benowitz NL, Jacob P III. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53: 316-23.
125. Department of Health and Human Services PHS. The health benefits of smoking cessation. A report of the Surgeon General. DHHS (CDC) Publication No. 90-8406. Washington DC: Government Printing Office; 1990.
126. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 3rd edition. Washington DC: American Psychiatric Association, 1994.
127. Shiffman SM. The tobacco withdrawal syndrome. In: National institute on drug abuse monograph no. 23. Bethesda MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse; 1979.
128. Breslau N, Kilbey MM, Andrewski P. Nicotine withdrawal symptoms and psychiatric disorders; Findings from an epidemiologic study of young adults. Am J Psychiatry 1992;149:464-9.
129. Pirie PL, Murray DM, Luepker RV. Gender differences in cigarette smoking and quitting in a cohort of young adults. Am J Public Health 1991; 81:324-7.
130. Tate JC, Pomerleau OF, Pomerleau CS. Temporal stability and within-subject consistency of nicotine withdrawal symptoms. J Substance Abuse 1993; 5:355-63.
131. Pomerleau CS, Tate JC, Lumley MA, Pomerleau OF. Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms. J Substance Abuse 1994;6:433-40.
132. Gunn RC. Reactions to withdrawal symptoms and success in smoking cessation clinics. Addict Behav 1986;11:49-53.
133. Svikis DS, Hatsukami DK, Hughes JR, Carroll KM, Pickens RW. Brief report: sex differences in tobacco withdrawal syndrome. Addict Behav 1986;11:459-62.
134. Hatsukami DK, McBride C, Pirie P, Hellerstedt W, Lando H. Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers. J Substance Abuse 1991;3:427-40.
135. Guilford JS. Sex differences between successful and unsuccessful abstainers from smoking. In: Zagona SV, editors. Studies and issues in smoking behavior. Tucson: University of Arizona Press; 1967, pp. 95-102.
136. Hatsukami DK, Skoog K, Allen S, Bliss R. Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Exp Clin Psychopharmacol 1995;3:163-73.
137. Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J consult Clin Psychiatry 1990;58:85-92.
138. Schneider NG, Jarvik ME, Forsythe AB. Nicotine versus placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 1984;9:149-56.
139. Repsher LH. Smoking cessation by women and older persons: results from the Transdermal Nicotine Study Group. Modern Med 1994;62:34-8.
140. Mello NK, Mendelson JH, Palmieri SL. Cigarette smoking by women: interactions with alcohol use. Psychopharmacology 1987;93:8-15.
141. Steinberg JL, Cherek DR. Menstrual cycle and cigarette smoking behavior. Addict Behav 1989; 14:173-9.
142. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG. Effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokes: a preliminary report. Psychoneuroendocrinology 1992;17:627-38.
143. DeBon N, Klesges RC, Klesges LM, Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addict Behav 1995;20: 335-43.
144. Allen SS, Hatsukami DK, Christianson D, Nelson D. Symptomatology and caloric intake during the menstrual cycle in smoking women. J Substance Abuse 1996;8:303-19.
145. Craig D, Parrott AC, Coomber J. Smoking cessation in women: effects of the menstrual cycle. Int J Addict 1992;27:697-706.
146. O'Hara P, Portser SA, Anderson BP. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict Behav 1989;14:595-600.
147. Allen SS, McBride CM, Pirie PL. The shortened premenstrual assessment form. J Reprod Med 1991;36:769-72.
148. Pomerleau CS, Garcia AW, Drewnowski A, Pomerleau OF. Sweet taste preference in women smokers: comparison with nonsmokers and effects of menstrual phase and nicotine abstinence. Pharmacol Biochem Behav 1991;40:995-9.
149. Pomerleau CS, Teuscher F, Goeters S, Pomerleau OF. Effects of nicotine abstinence and menstrual phase on task performance. Addict Behav 1994; 19:357-62.
150. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition, revised (DSM-IIIR). Washington DC: American Psychiatric Association; 1987.
151. Breslau N, Kilbey MM, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 1991;48: 1069-74.
152. Breslau N, Kilbey MM, Andreski P. Nicotine dependence and major depression: new evidence from a prospective investigation. Arch Gen Psychiatry 1993;50:31-5.
153. Dalack GW, Glassman AH, Rivelli S, Covey L, Stetner F. Mood, major depression and fluoxetine response in cigarette smokers. Am J Psychiatry 1995;152:398-403.
154. Hall SM, Munoz RF, Reus VI, Sees KL. Nicotine, negative affect and depression. J Consult Clin Psychol 1993;61:761-7.
155. Glassman AH, Helzer JE, Covey LS et al. Smoking, smoking cessation and major depression. JAMA 1990;264:1546-9.
156. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993;50:36-43.
157. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA 1990;264:1541-5.
158. Frederick T, Frerichs RR, Clark VA. Personal health habits and smptoms of depression at the community level. Prev Med 1988;17:173-82.
159. Lee DJ, Markides KS. Health behaviors, risk factors, and health indicators associated with cigarette use in Mexican Americans: results from the Hispanic HANES. Am J Public Health 1991;81: 859-64.
160. Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993;150: 546-53.
161. Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP. Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann Behav Med 1997;19:42-50.
162. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Comp Psychiatry 1990;31:350-4.
163. Glassman AH, Stetner F, Walsh BT et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988; 259:2863-6.
164. Covey LS, Glassman AH, Stetner F, Becker J. Effect of history of alcoholism or major depression on smoking cessation. Am J Psychiatry 1993;150: 1546-7.
165. Ginsberg D, Hall SM, Reus VI, Munoz RF. Mood and depression diagnosis in smoking cessation. Exp Clin Psychopharmacol 1995;3:389-95.
166. Breslau N, Kilbey MM, Andreski P. Vulnerability to psychopathology in nicotine-dependent smokers: an epidemiologic study of young adults. Am J Psychiatry 1993;150:941-6.
167. Wikler A. Conditioning factors in opiate addiction and relapse. In: Wilner DI, Kassenbaum GG, editors. Narcotics. New York: McGraw-Hill; 1965, pp. 85-100.
168. Siegel S. Classical conditioning, drug tolerance, and drug dependence. In: Israel Y, Glaser FB, Kalant RE, Popham RE, Schmidt W, Smart RG, editors. Research advances in alcohol and drug problems. New York: Plenum Press; 1983, pp. 207-46.
169. Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 1984;91:251-68.
170. Rickard-Figueroa K, Zeichner A. Assessment of smoking urge and its concomitants under an environmental smoking cue manipulation. Addict Behav 1985;10:246-56.
171. Tiffany ST, Hakenewerth DM. The production of smoking urges through an imagery manipulation; psychophysiological and verbal manifestations. Addict Behav 1991;16:389-400.
172. Herman PC. External and internal cues as determinants of the smoking behavior of light and heavy smokers. J Personal Soc Psychol 1974;30: 664-72.
173. Payne TJ, Schare ML, Levis DJ, Colletti G. Exposure to smoking-relevant cues: effects on desire to smoke and topographical components of smoking behavior. Addict Behav 1991;16:467-79.
174. Saumet JL, Dittmar A. Heat loss and anticipatory finger vasoconstriction induced by smoking of a single cigarette. Physiol Behav 1985;35:229-32.
175. Abrams DB, Monti PM, Carey KB, Pinto RP, Jacobus SI. Reactivity to smoking cues and relapse: two studies of discriminant validity. Behav Res Ther 1988;26:225-33.
176. Niaura R, Abrams D, Demuth B, Pinto R, Monti P. Responses to smoking-related stimuli and early relapse to smoking. Addict Behav 1989;14: 419-28.
177. Sayette MA, Hufford MR. Urge and affect: a facial coding analysis of smokers. Exp Clin Psychol 1995;3:417-23.
178. Rose JE, Levin ED. Interrelationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict 1991;86:605-9.
179. Stolerman IP, Goldfarb T, Fink R, Jarvik ME. Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 1973;28: 247-59.
180. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R. Sensory blockade of smoking satisfaction. Pharmacol Biochem Behav 1985;23:289-93.
181. Behm FM, Schur C, Levin ED, Tashkin DP, Rose JE. Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend 1993; 31:131-8.
182. Behm FM, Levin ED, Lee YK, Rose JE. Low-nicotine regenerated smoke aerosol reduces desire for cigarettes. J Substance Abuse 1990;2:237-47.
183. Rose JE, Behm FM. Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. Drug Alcohol Depend 1994;34: 225-9.
184. Rose JE, Hickman CS. Citric acid aerosol as a potential smoking cessation aid. Chest 1987;92: 1005-8.
185. Westman EC, Behm FM, Rose JE. Airway sensory replacement combined with nicotine replacement for smoking cessation: a randomized, placebo-controlled trial using a citric acid inhaler. Chest 1995;107:1358-64.
186. Rose JE, Behm FM, Levin ED. Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacol Biochem Behav 1993;44: 891-900.
187. Levin ED, Rose JE, Behm FM, Caskey NH. The effects of smoking-related sensory cues on psychological stress. Pharmacol Biochem Behav 1991;39:265-8.
188. Baldinger B, Hasenfratz M, Battig K. Switching to ultralow nicotine cigarettes: effects of different tar yields and blocking of olfactory cues. Pharmacol Biochem Behav 1995;50:233-9.
189. Hasenfratz M, Baldinger B, Battig K. Nicotine or tar titration in cigarette smoking behavior? Psychopharmacology 1993;112:253-8.
190. Hofer I, Nil R, Battig K. Ultralow-yield cigarettes and type of ventilation: the role of ventilation blocking. Pharmacol Biochem Behav 1991;40: 907-14.
191. Glassman AH, Covery LS, Dalack GW et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993;54:670-9.